Association between elevated serum VEGF and polarographically measured tumor hypoxia in carcinomas of the head and neck;Assoziation zwischen erhöhten serum-VEGF-werten und polarographisch gemessener tumorhypoxie bei patienten mit kopf-hals-karzinomen

Strahlentherapie und Onkologie

Volumn 177, Issue 4, 2001, Pages 182-188

  Becker, Axel ^a   Stadler, Peter ^b   Krause, Ulf ^a   Utzig, Dorothea ^a   Hänsgen, Gabriele ^a   Lautenschläger, Christine ^a   Rath, Friedrich Wilhelm ^a   Molls, Michael ^b   Dunst, Jürgen ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Head and neck carcinoma; Hypoxia; Platelet count; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CORRELATION FUNCTION; COVARIANCE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; OXYGENATION; POLAROGRAPHY; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT;

EID: 0035048483     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-001-0809-3     Document Type: Article

References (30)

1. Release of the angiogenetic cytocine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
2. Oxygenierungsstatus von plattenepithelkarzinomen der kopf-hals-region
3. Vascular endothetial growth factor as a marker of tumor endothelium
4. Prognostische bedeutung von bFGF, VEGF und MMP-2 im serum von patienten mit fortgeschrittenen kopf-hals-tumoren
5. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer
6. Cervix cancer oxygenation measured following external radiation therapy
7. Pretreatment and midtreatment measurements of oxygen tension levels in head and neck cancers
8. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer
9. Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood
10. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
11. Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma
12. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
13. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix
14. Morphological aspects of tumor angiogenesis and microcirculation
15. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
16. In vitro release of vascular endothelial growth factor during platelet aggregation
17. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
18. Measurements of the human tumor oxygenation status by polarographic needle electrode
19. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker
20. Angiogenetic growth factors
21. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma
22. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
23. Influence of the hypoxic subvolume on survival of patients with head and neck cancer
24. Fibroblast response to hypoxia: The relationship between angiogenesis and matrix regulation
25. Platelet: Transporter of vascular endothelial growth factor
26. Vascular endothelial growth factor (VEGF) is relased from platelets during blood clotting: Implications for measurement of circulation VEGF levels in clinical disease
27. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo
28. Concentration of vascular endothelial growth factor in the sera of normal controls and cancer patients
29. Hat eine operation im kopf-hals-bereich einen einfluß auf die VEGF-konzentration im serum?